+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmacovigilance and Drug Safety Software Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Software Type; Delivery Mode; and End User, and Geography

  • ID: 4847180
  • Report
  • January 2021
  • Region: Global
  • 186 Pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021
Rising Incidences of Adverse Drug Reaction (ADR), Globalization of Pharmacovigilance

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO
  • IQVIA Inc.
  • Maxapplication

Adverse Event Reporting Software Segment to Grow at Highest CAGR During 2020-2027

According to the research study, the market is expected to reach US$ 292.97 million in 2027 from US$ 160.67 million in 2019. The market is estimated to grow at a CAGR of 7.6% from 2020 to 2027.

The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as rising incidences of adverse drug reaction (ADR) and globalization of pharmacovigilance have been boosting the market over the years. However, the expensive technology is likely to have a negative impact on the growth of the market in the coming years.

AB Cube, United BioSource LLC, ARISGLOBAL LLC, Sparta Systems, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd., EXTEDO, ENNOV, Max Application and Anju Software, Inc. are among the leading companies operating in the pharmacovigilance and drug safety software market. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the pharmacovigilance and drug safety software.

For instance, in Aug 2019, Veeva Systems unveiled Veeva Vault Safety.AI, a new artificial intelligence technology that automates case intake in order to reduce the time and effort spent on manual data entry. To complement Vault Safety and Vault SafetyDocs, Veeva provides the first integrated suite of cloud applications on a shared platform to control the end-to-end drug safety lifecycle.

Software Type-based Insights

Based on software type the market is segmented into adverse event reporting software, drug safety audits software, issue tracking software, and fully integrated software. In 2019, the adverse event reporting software segment held the largest share of the market, by software. However, the fully integrated software segment is anticipated to grow at the highest rate during the forecast period owing to its accuracy to avoid data redundancy by eliminating errors and tracking individual case safety reports.
 
Delivery Mode-based Insights

Based on delivery mode the market is segmented into on premise and cloud based. In 2019, the on-premise segment held the largest share of the market, by delivery mode. However, Cloud based segment is expected to grow at the fastest rate during the coming years owing to the benefits associated such as remote access to data, real-time data tracking.

End User-based Insights

Based on end user the market is segmented into pharmaceutical and biotech companies, contract research organizations (CROs) and business process outsourcing (BPO) Firms. In 2019, the contract research organizations segment held the largest share of the market, by end user. Moreover, Contract Research Organizations segment is expected to grow at the fastest rate during the coming years owing to increasing drug discovery activities in the pharmaceutical companies.

Strategic Insights

Inorganic strategies such as partnerships, and mergers and acquisitions are commonly adopted by companies to cater to changing customer demand and maintain their brand name across the world. Market players operating in the pharmacovigilance and drug safety software market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide as well as to meet the growing demand.

The report segments the global pharmacovigilance and drug safety software market as follows:

By Software Type

  • Fully Integrated Software
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software

By Delivery Mode

  • Cloud-based
  • On-premise

By End User

  • Contract Research Organizations
  • Pharmaceutical and Biotech Companies
  • Business Process Outsourcin

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of APAC
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmacovigilance and drug safety software market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global pharmacovigilance and drug safety software market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Cube
  • ArisGlobal LLC
  • Ennov
  • EXTEDO
  • IQVIA Inc.
  • Maxapplication

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Software Type
1.3.2 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Delivery Mode
1.3.3 Global Pharmacovigilance (PV) and Drug Safety Software Market - By End User
1.3.4 Global Pharmacovigilance (PV) and Drug Safety Software Market - By Geography

2. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Pharmacovigilance (PV) and Drug Safety Software Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East & Africa PEST Analysis
4.2.5 South & Central America PEST Analysis
4.3 Expert Opinions

5. Global Pharmacovigilance (PV) and Drug Safety Software Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Incidences Of Adverse Drug Reactions (ADRs)
5.1.2 Globalization Of Pharmacovigilance
5.2 Key Market Restraints
5.2.1 Expensive Technology
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence In Pharmacovigilance
5.5 Impact Analysis

6. Pharmacovigilance (PV) and Drug Safety Software Market - Global Analysis
6.1 Global Pharmacovigilance (PV) and Drug Safety Software Market Revenue Forecasts And Analysis
6.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography - Forecasts And Analysis
6.3 Performance of Key Players

7. Global Pharmacovigilance (PV) And Drug Safety Software Analysis by Software Type
7.1 Overview
7.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Product & Services 2019 & 2027 (%)
7.3 Adverse Event Reporting Software Market
7.3.1 Overview
7.3.2 Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 Drug Safety Audits Software
7.4.1 Overview
7.4.2 Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Issue Tracking Software
7.5.1 Overview
7.5.2 Global Issue Tracking Software Market Revenue and Forecasts to 2027 (US$ Mn)
7.6 Fully Integrated Software
7.6.1 Overview
7.6.2 Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis by Delivery Mode
8.1 Overview
8.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By Delivery Mode 2019 & 2027 (%)
8.3 On-premise Market
8.3.1 Overview
8.3.2 Global On-premise Market Revenue and Forecasts to 2027 (US$ Mn)
8.4 Cloud- Based Market
8.4.1 Overview
8.4.2 Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)

9. Global Pharmacovigilance (PV) and Drug Safety Software Market Analysis by End User
9.1 Overview
9.2 Global Pharmacovigilance (PV) and Drug Safety Software Market, By End User 2019 & 2027 (%)
9.3 Pharmaceutical and Biotech Companies Market
9.3.1 Overview
9.3.2 Global Pharmaceutical and Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Contract Research Organizations (CROs) Market
9.4.1.1 Overview
9.4.1.2 Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Business Process Outsourcing (BPO) Firms Market
9.5.1 Overview
9.5.2 Global Business Process Outsourcing (BPO) Firms Market Revenue and Forecasts to 2027 (US$ Mn)

10. Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 - Geographical Analysis
10.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.1.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.2.1 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.2.2 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.3 North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.1.4 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.5 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.6 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.6.1 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.6.2 US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.7 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.7.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.8 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.8.1 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.8.2 Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.1.9 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.9.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.1.10 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.1.10.1 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.1.10.2 Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.2.1 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.2.2 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.3 Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.2.4 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.5 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.6 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.6.1 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.6.2 UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.7 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.7.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.8 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.8.1 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.8.2 Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.8.3 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.9 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.10 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.10.1 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.10.2 France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.11 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.11.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.12 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.12.1 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.12.2 Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.13 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.14 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.15 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.15.1 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.15.2 Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.2.16 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.17 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.2.18 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.2.18.1 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.2.18.2 Rest of Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.3.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.2.1 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.2.2 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.3 Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.3.4 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.5 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.6 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.6.1 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.6.2 Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.6.3 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.7 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.8 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.8.1 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.8.2 China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.9 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.10 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.11 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.11.1 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.11.2 India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.12 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.13 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.14 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.14.1 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.14.2 South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.15 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.16 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.17 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.17.1 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.17.2 Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.3.18 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.19 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.3.20 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.3.20.1 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.3.20.2 Rest of Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.4.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.2.1 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.2.2 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.3 Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.4.4 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.5 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.6 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.6.1 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.6.2 UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.7 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.7.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.8 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.8.1 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.8.2 Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.9 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.10 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.11 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.11.1 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.11.2 South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.4.12 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.13 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.4.14 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.4.14.1 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.4.14.2 Rest of Middle East and Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5 South And Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027
10.5.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.2.1 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.2.2 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.3 South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
10.5.4 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.5 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.6 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.6.1 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.6.2 Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.7 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.8 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.9 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.9.1 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.9.2 Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
10.5.10 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.11 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
10.5.12 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
10.5.12.1 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
10.5.12.2 Rest of South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)

11. Pharmacovigilance (PV) and Drug Safety Software Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Growth Strategies by Companies

12. Pharmacovigilance (PV) and Drug Safety Software Market - Key Company Profiles
12.1 Veeva Systems
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 IQVIA Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ennov
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AB Cube
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 United Biosource LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ArisGlobal LLC
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Sparta Systems
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oracle Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Sarjen Systems Pvt. Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 EXTEDO
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Maxapplication
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Online Business Applications, Inc.
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

List of Tables
Table 1. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 2. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 3. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 4. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 5. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 6. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 7. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 8. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 9. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 10. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 11. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 12. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 13. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 14. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 15. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 16. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 17. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 18. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 19. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 20. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 21. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 22. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 23. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 24. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 25. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 26. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 27. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 28. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 29. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 30. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 31. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 32. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 33. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 34. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 35. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 36. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 37. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 38. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 39. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 40. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 41. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 42. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 43. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 44. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 45. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 46. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 47. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 48. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 49. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 50. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 51. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 52. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 53. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 54. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 55. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 57. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 58. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 59. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 60. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 61. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 62. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 63. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 64. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 65. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 66. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 67. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Software Type(US$ Mn)
Table 68. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Delivery Mode (US$ Mn)
Table 69. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By End User (US$ Mn)
Table 70. Recent Organic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 71. Recent Inorganic Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market
Table 72. Glossary of Terms, Pharmacovigilance (PV) and Drug Safety Software Market

List of Figures
Figure 1. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation
Figure 2. Pharmacovigilance (PV) and Drug Safety Software Market Segmentation, by Region
Figure 3. Global Pharmacovigilance (PV) and Drug Safety Software Market Overview
Figure 4. Adverse Event Reporting Software Segment Held Largest Share Of The Software Type Segment In Pharmacovigilance (PV) and Drug Safety Software Market
Figure 5. Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period
Figure 6. Global Pharmacovigilance (PV) and Drug Safety Software Market, By Geography (US$ Mn)
Figure 7. Global Pharmacovigilance (PV) and Drug Safety Software Market- Leading Country Markets (US$ Mn)
Figure 8. Global Pharmacovigilance (PV) and Drug Safety Software Market, Industry Landscape
Figure 9. North America : PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia - Pacific: PEST Analysis
Figure 12. Middle East & Africa: PEST Analysis
Figure 13. South & Central America: PEST Analysis
Figure 14. Impact Analysis of Driver and Restraints Pertaining to Pharmacovigilance (PV) and Drug Safety Software Market
Figure 15. Global Pharmacovigilance (PV) and Drug Safety Software Market - Revenue Forecasts and Analysis - 2018- 2027
Figure 16. Global Pharmacovigilance (PV) and Drug Safety Software Market - by Geography Forecasts and Analysis - 2018- 2027
Figure 17. Prominent Players in the Pharmacovigilance (PV) and Drug Safety Software Market
Figure 18. Global Pharmacovigilance (PV) and Drug Safety Software Market, by Product & Services 2019 & 2027 (%)
Figure 19. Global Adverse Event Reporting Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Global Drug Safety Audits Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Global Fully Integrated Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Global Pharmacovigilance (PV) and Drug Safety Software Market, by Delivery Mode 2019 & 2027 (%)
Figure 24. Global Chemical Compounds Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Global Cloud Based Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Global Pharmacovigilance (PV) and Drug Safety Software Market, by End User 2019 & 2027 (%)
Figure 27. Global Pharmaceutical And Biotech Companies Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 28. Global Contract Research Organizations (CROs) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Global Business Process Outsourcing (BPO) Firms Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 31. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 32. North America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 33. US Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 34. Canada Pharmacovigilance (PV) and Drug Safety Software Market Revenue And Forecasts To 2027 (US$ Mn)
Figure 35. Mexico Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 36. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 37. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 38. Europe Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 39. UK Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 40. Germany Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 41. France Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 42. Italy Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 43. Spain Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 44. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 45. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 46. Asia Pacific Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 47. Japan Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 48. China Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 49. India Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 50. South Korea Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 51. Australia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 52. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 53. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 54. Middle East & Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 55. UAE Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 56. Saudi Arabia Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 57. South Africa Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 58. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue Overview, By Country, 2018 (US$ Mn)
Figure 59. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 60. South and Central America Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027, By Country (%)
Figure 61. Argentina Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 62. Brazil Pharmacovigilance (PV) and Drug Safety Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 63. Growth Strategies in the Pharmacovigilance (PV) and Drug Safety Software Market, 2016-2019

Note: Product cover images may vary from those shown

Loading
LOADING...

  • Veeva Systems
  • IQVIA Inc.
  • Ennov
  • AB Cube
  • United Biosource LLC
  • ArisGlobal LLC
  • Sparta Systems
  • Oracle Corporation
  • Sarjen Systems Pvt. Ltd
  • EXTEDO
  • Maxapplication
  • Online Business Applications, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll